Testing effectiveness (Phase 2)Study completedNCT01878201
What this trial is testing
A Valsartan 80 Mg-Referenced, Therapeutic Exploratory Clinical Study to Evaluate the Antihypertensive Efficacy of Fimasartan 30 mg During 24 Hours in Patients With Mild to Moderate Essential Hypertension
Who this might be right for
Essential Hypertension
Boryung Pharmaceutical Co., Ltd 75